The expression of cytokines and chemokines potentially distinguishes mild and severe psoriatic non-lesional and resolved skin from healthy skin and indicates different stages of inflammation

In the psoriatic non-lesional (PS-NL) skin, the tissue environment potentially influences the development and recurrence of lesions. Therefore, we aimed to investigate mechanisms involved in regulating tissue organization in PS-NL skin. Cytokine, chemokine, protease, and protease inhibitor levels we...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Bozó Renáta
Flink Lili Borbála
Ambrus Barbara
Ghaffarinia Ameneh
Koncz Balázs
Kui Róbert
Gyulai Rolland Péter
Kemény Lajos
Csörgő Sándorné Bata Zsuzsanna
Dokumentumtípus: Cikk
Megjelent: 2024
Sorozat:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 25 No. 20
Tárgyszavak:
doi:10.3390/ijms252011292

mtmt:35481281
Online Access:http://publicatio.bibl.u-szeged.hu/35002
LEADER 02817nab a2200313 i 4500
001 publ35002
005 20241029114137.0
008 241029s2024 hu o 000 eng d
022 |a 1661-6596 
024 7 |a 10.3390/ijms252011292  |2 doi 
024 7 |a 35481281  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a eng 
100 1 |a Bozó Renáta 
245 1 4 |a The expression of cytokines and chemokines potentially distinguishes mild and severe psoriatic non-lesional and resolved skin from healthy skin and indicates different stages of inflammation  |h [elektronikus dokumentum] /  |c  Bozó Renáta 
260 |c 2024 
300 |a 25 
490 0 |a INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES  |v 25 No. 20 
520 3 |a In the psoriatic non-lesional (PS-NL) skin, the tissue environment potentially influences the development and recurrence of lesions. Therefore, we aimed to investigate mechanisms involved in regulating tissue organization in PS-NL skin. Cytokine, chemokine, protease, and protease inhibitor levels were compared between PS-NL skin of patients with mild and severe symptoms and healthy skin. By comparing mild and severe PS-NL vs. healthy skin, differentially expressed cytokines and chemokines suggested alterations in hemostasis-related processes, while protease inhibitors showed no psoriasis severity-related changes. Comparing severe and mild PS-NL skin revealed disease severity-related changes in the expression of proteases, cytokines, and chemokines primarily involving methyl-CpG binding protein 2 (MECP2) and extracellular matrix organization-related mechanisms. Cytokine and chemokine expression in clinically resolved versus healthy skin showed slight interleukin activity, differing from patterns in mild and severe PS-NL skin. Immunofluorescence analysis revealed the severity-dependent nuclear expression pattern of MECP2 and decreased expression of 5-methylcytosine and 5-hydroxymethylcytosine in the PS-NL vs. healthy skin, and in resolved vs. healthy skin. Our results suggest distinct cytokine-chemokine signaling between the resolved and PS-NL skin of untreated patients with varying severities. These results highlight an altered inflammatory response, epigenetic regulation, and tissue organization in different types of PS-NL skin with possibly distinct, severity-dependent para-inflammatory states. 
650 4 |a Klinikai orvostan 
700 0 1 |a Flink Lili Borbála  |e aut 
700 0 1 |a Ambrus Barbara  |e aut 
700 0 1 |a Ghaffarinia Ameneh  |e aut 
700 0 1 |a Koncz Balázs  |e aut 
700 0 1 |a Kui Róbert  |e aut 
700 0 1 |a Gyulai Rolland Péter  |e aut 
700 0 1 |a Kemény Lajos  |e aut 
700 0 2 |a Csörgő Sándorné Bata Zsuzsanna  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/35002/1/BozoR.Theexpressionofcytokines_2024_szc._IJMS.pdf  |z Dokumentum-elérés